Power Law company profile

Xeris Pharmaceuticals

Biotech & Life Sciences · Chicago, United States · Founded 2005 · IPO 2018 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$1.19B

Market cap · Apr/2026

Revenue

$292M

Latest reported FY

Investors

3 investors on Xeris Pharmaceuticals's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 1 investor entered at this stage

Central Texas Angel Network

Series B+ 2 investors entered at this stage

Redmile Group

Texas Venture Labs

Global footprint

Where Xeris Pharmaceuticals has talent and traffic

Web traffic by country

15K monthly visits
across markets

🇺🇸 United States71.3%

🇦🇺 Australia10%

🇮🇳 India8.7%

🇬🇧 United Kingdom6%

🇨🇦 Canada4.7%

Top 5 markets shown

Patent intelligence

$39M patent portfolio · 25 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$39M

3.3% of market cap · 13.3× smaller than top peer ChemoCentryx ($524M)

25 active patent families

Where Xeris Pharmaceuticals innovates DiseaseCancerIsotonic SolutionsAcromegalyHormones regulation

Above peer median on Legal, Strategic, Market, Technology

Quality vs same-sector peers

Xeris Pharmaceuticals on the five Patsnap quality dimensions

Xeris Pharmaceuticals in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Xeris Pharmaceuticals concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Xeris Pharmaceuticals and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Xeris Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo